2.140USD+7.54%Mkt Cap: 84.42M $P/E: —2d ago
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM t…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap84.42M $
Enterprise Value39.40M $
Revenue (TTM)70.00K $
Gross Profit-83.00K $
Net Income (TTM)-31.93M $
Revenue/Share0.0010 USD
Last Price2.140 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees71
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.93
PEG—
EV/EBITDA-1.08
EV/Revenue562.86
P/S1183.48
P/B1.22
EPS (TTM)-0.68
EPS (Forward)-0.54
52W Range
1.56024% of range3.950
52W High3.950 USD
52W Low1.560 USD
Profitability
Gross Margin-102.47%
Oper. Margin-33346.67%
EBITDA Margin0.00%
Profit Margin-39417.28%
ROE-42.34%
ROA-31.32%
Growth
Revenue Growth76.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.62M $
CapEx (TTM)726.00K $
FCF Margin-26985.18%
FCF Yield-22.38%
Net Debt-43.44M $
Net Debt/EBITDA1.19
Balance Sheet
Debt/Equity0.03
Current Ratio1.98
Quick Ratio1.91
Book Value/Sh1.727 USD
Cash/Share1.177 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.500 USD
Upside (mean)+157.0%
Target Range5.000 USD – 6.000 USD
$5.000+157.0% to mean$6.000
# Analysts2
Ownership
Shares Out.38.48M
Float27.76M
Insiders11.92%
Institutions50.19%
Short Interest
Short Ratio6.4d
Short % Float0.74%
Short % Out.0.59%
Shares Short230.88K
Short (prev mo.)262.55K
Technical
SMA 501.988 (+7.7%)
SMA 2002.422 (-11.6%)
Beta0.98
S&P 52W Chg18.16%
Avg Vol (30d)36.77K
Avg Vol (10d)30.24K
Technical Indicators
RSI (14)48.3
MACD-0.0117
MACD Signal-0.0009
MACD Hist.-0.0108
BB Upper2.144 USD
BB Middle2.030 USD
BB Lower1.916 USD
BB Width11.26%
ATR (14)0.1500 USD
Vol Ratio (20d)0.67x